E. Ståhle

Benefits of extended treatment with dalteparin in patients with unstable coronary artery disease eligible for revascularization (2002)

Husted, S.E., Wallentin, L., Lagerqvist, B., Kontny, F., Ståhle, E., Swahn, E.

Aims The FRISC II trial demonstrated that, for patients with unstable coronary artery disease, an early invasive strategy following acute treatment with dalteparin and aspirin, was superior to a more...

Impact of perioperative myocardial injury on early and long-term outcome after coronary artery bypass grafting (2002)

Steuer, J., Lindahl, B., Ståhle, E.

Aims To establish the influence of perioperative myocardial injury on short- and long-term survival after coronary artery bypass grafting (CABG). Methods and Results The correlation of postoperative...

Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis (2000)

Kvidal, P, Bergström, R, Malm, T, Ståhle, E

Aims The aim of this study was to determine the incidence of valve-related complications in patients with a mechanical aortic valve prosthesis and to identify risk factors for an adverse outcome....

Patients with ischaemic heart disease and severe left ventricular dysfunction -- who should not be revascularized? (2000)

Ståhle, E.

Increased risk of heart failure as a consequence of perioperative myocardial injury after coronary artery bypass grafting

Steuer, J, Granath, F, De Faire, U, Ekbom, A, Ståhle, E

Objective: To analyse the relation between perioperative myocardial injury (PMI) and the risk of subsequent heart failure after coronary artery bypass grafting (CABG).

FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease

Lagerqvist, B, Diderholm, E, Lindahl, B, Husted, S, Kontny, F, Ståhle, E, ...

Objective: To develop a scoring system for risk stratification and evaluation of the effect of an early invasive strategy for treatment of unstable coronary artery disease (CAD).

Temporal trends in non-small cell lung cancer survival in Sweden

Brooks, D R, Klint, Å, Dickman, P W, Ståhle, E, Lambe, M

We modeled temporal trends in the 1- and 5-year survival of 32 499 patients with adenocarcinoma and squamous cell carcinoma of the lung in the Swedish Cancer Register between 1961 and 2000. The...